Smarter mAb Development with AI
From cell culture decisions to confident scale-up.
BIOLOGICS FORUM×BioMedAna by OpenAna
THE INTELLIGENT BIOPROCESS SERIES · WEBINAR 02
How AI can support expression, process optimization, scale-up and faster development.
A grounded expert discussion on turning experimental and process evidence into better recombinant-protein development decisions.
THE FOUR-PART SERIES
Start with the completed mAb session, register for recombinant proteins, and follow the upcoming hybrid-twin and fermentation conversations.
From cell culture decisions to confident scale-up.
Smarter experimentation, expression optimization and faster development.
Biology + physics + process data + AI for predictive decisions.
Turning dynamic process signals into predictive decisions.
SESSION 02 — 9 OCTOBER 2026
How can teams connect expression, experimental and process data to improve development choices, reduce avoidable experimental burden and prepare for more confident scale-up?
Bring host, construct, media, feed, analytical and process context into a reusable scientific record.
Use data and domain constraints to compare conditions and focus the next round of development work.
Evaluate which relationships may transfer, which are scale-dependent and where targeted evidence is still needed.
THE CONVERSATION
From expression data to connected evidenceHow to preserve the context across constructs, hosts, media, feeds and analytical results.
Smarter experimentationWhere AI, multivariate analysis and scientific constraints can help prioritize the next experiment.
Quality, yield and robustnessHow teams can evaluate competing objectives without optimizing one headline metric in isolation.
Scale-up and technology transferHow hybrid modeling can combine biology, data and engineering descriptors while keeping scientists in control.
EDUCATION · EXPERT DISCUSSION · PRACTICAL AI
Join scientists, engineers and digital leaders for a practical discussion of where AI can strengthen recombinant-protein development—and where scientific review remains essential.
Explore webinar 01 ↗